background image
Pictured at RCSI Research Day 2014 were (l-r)
William Arthur Lackington, PhD student in
Bioengineering and Regenerative Medicine;
and Professor John Waddington, Professor
of Neuroscience, RCSI.
help with the development of a new
class of anti-diarrhoeal medication.
The research was published in gut
(2014 May, 63:808-17). Dr. Stephen
Keely was senior author of the study.
Childhood trauma linked to
psychotic experiences
Researchers at RCSI demonstrated
that exposure to childhood trauma
(physical assault and bullying) is
linked to psychotic experiences (such
as hearing voices), and, in turn, the
cessation of traumatic experiences
leads to a significant reduction in the
incidence of psychotic experiences.
These findings place new weight
on calls for more comprehensive
preventions and intervention strategies
against childhood trauma in the
community from abuse at home and
bullying in schools. The paper, entitled
"Childhood trauma and psychosis in
a prospective cohort study: cause,
effect, and directionality" was
published in the American Journal
of Psychiatry (2013 Jul, 170:734-41),
with Professor Mary Cannon as
senior author.
Identifying those at increased
risk of developing COPD
Professor gerry McElvaney, and his
team of researchers from RCSI, the
Alpha One Foundation and Harvard
University made a major breakthrough
in identifying a significant proportion
of the population who have an
increased risk of developing chronic
obstructive pulmonary disease
(COPD) due to a combination of
inherited genes and exposure to
cigarette smoke.
Their paper, entitled "Clarification
of the risk of chronic obstructive
pulmonary disease in Alpha
1-Antitrypsin deficiency PiMZ
heterozygotes", was published in the
American Journal of Respiratory and
Critical Care Medicine (2014 February,
rcsi recognises that
excellence in research
is critical to the quality
of its educational
activities and its
mission to enhance
human health.
Pictured at the RCSI Human Disease Mapping conference was keynote speaker Professor
Helen Mayberg, Emory University School of Medicine, Atlanta, USA, renowned pioneer of
deep brain stimulation which is used to treat conditions such as depression.